Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Preferred Dividend Payments (2022 - 2025)

Historic Preferred Dividend Payments for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $1.3 million.

  • Envoy Medical's Preferred Dividend Payments fell 833.33% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 8305.45%. This contributed to the annual value of $5.5 million for FY2024, which is 30926.61% up from last year.
  • Per Envoy Medical's latest filing, its Preferred Dividend Payments stood at $1.3 million for Q3 2025, which was down 833.33% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Preferred Dividend Payments registered a high of $26.4 million during Q4 2023, and its lowest value of -$1.3 million during Q3 2022.
  • For the 4-year period, Envoy Medical's Preferred Dividend Payments averaged around $3.6 million, with its median value being $1.4 million (2024).
  • Per our database at Business Quant, Envoy Medical's Preferred Dividend Payments surged by 21672.89% in 2023 and then tumbled by 9465.04% in 2024.
  • Quarter analysis of 4 years shows Envoy Medical's Preferred Dividend Payments stood at -$1.3 million in 2022, then surged by 2069.83% to $26.4 million in 2023, then crashed by 94.65% to $1.4 million in 2024, then dropped by 10.35% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.3 million for Q2 2025, and $1.2 million during Q1 2025.